Shire to consider revised Takeda bid

Shire plc (LSE:SHP; NASDAQ:SHPG) said late Tuesday its board is willing to recommend to shareholders a revised takeover bid from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) that values Shire at about £46 billion ($64.4 billion) and would equate to about a 50% stake of the combined company.

Shire's board extended to May 8 the deadline to finalize the proposal and said it would engage in discussions with Takeda to resolve "other terms" of the offer including the completion of due diligence by Shire on Takeda...